Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Mineralys Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:MLYS | Benzinga

Q: What sector and industry does Mineralys Therapeutics (MLYS) operate in?

Mineralys Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Mineralys Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MLYS.

Open	-
Close	-
Volume / Avg.	18.00 / 1.12M
Day Range	- - -
52 Wk Range	8.24 - 18.38
Market Cap	$892.37M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	12.95%
Days to Cover	4.58

Recent News

Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate

Mineralys Therapeutics' lorundrostat met key Phase 3 and Phase 2 trial endpoints for hypertension, showing significant blood pressure reductions and a strong safety profile.

Vandana Singh

Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	18.00 / 1.12M
Day Range	- - -
52 Wk Range	8.24 - 18.38
Market Cap	$892.37M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	12.95%
Days to Cover	4.58

About Mineralys Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medic...

Got Questions? Ask

Analyze MLYS's financials

Show MLYS's technical analysis

What is MLYS's current price trend?

What is MLYS's drawdown from recent high?

What is MLYS's operating cash flow?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Mineralys Therapeutics (MLYS) stock?

You can purchase shares of Mineralys Therapeutics (NASDAQ:MLYS) through any online brokerage.

View our list of the best stock brokerages

Who are Mineralys Therapeutics (MLYS) competitors?

Other companies in Mineralys Therapeutics’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), KalVista Pharma (NASDAQ:KALV), Gyre Therapeutics (NASDAQ:GYRE) and Replimune Group (NASDAQ:REPL).

What is the forecast, or price target, for Mineralys Therapeutics (MLYS) stock?

Mineralys Therapeutics has a consensus price target of $35.67.

What is the current price for Mineralys Therapeutics (MLYS)?

The stock price for Mineralys Therapeutics (NASDAQ: MLYS) is $14.21 last updated April 30, 2025 at 4:00 PM EDT.

Does Mineralys Therapeutics (MLYS) pay a dividend?

There are no upcoming dividends for Mineralys Therapeutics.

When is Mineralys Therapeutics (NASDAQ:MLYS) reporting earnings?

Mineralys Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Mineralys Therapeutics (MLYS) going to split?

There is no upcoming split for Mineralys Therapeutics.

What sector and industry does Mineralys Therapeutics (MLYS) operate in?

Mineralys Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Mineralys Therapeutics Stock Price, Quotes and Forecasts

Mineralys Therapeutics (MLYS) Forecast